Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 18, 2022

SELL
$7.06 - $23.63 $69,703 - $233,298
-9,873 Closed
0 $0
Q1 2022

Apr 28, 2022

SELL
$21.6 - $27.79 $5,400 - $6,947
-250 Reduced 2.47%
9,873 $226,000
Q4 2021

Feb 10, 2022

BUY
$23.0 - $29.01 $232,829 - $293,668
10,123 New
10,123 $279,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $3.07B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Intrinsic Value Partners, LLC Portfolio

Follow Intrinsic Value Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrinsic Value Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intrinsic Value Partners, LLC with notifications on news.